Oral Vinorelbine and Cisplatin with Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Publisher： Karger

E-ISSN： 2296-5262|29|4|137-142

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.4, 2006-03, pp. : 137-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non–small cell lung cancer (NSCLC)

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1321-1327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Short Schedule of Cisplatin and Vinorelbine: A Dose-Finding Study in Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non‐small cell lung cancer in the National Cancer Data Base

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2060-2068

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted therapy in lung cancer

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 370-378

John Wiley & Sons Inc

Access to resources Recommend Favorite